These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21763442)

  • 1. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
    Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
    Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.
    Lebedev AV; Westman E; Van Westen GJ; Kramberger MG; Lundervold A; Aarsland D; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Simmons A;
    Neuroimage Clin; 2014; 6():115-25. PubMed ID: 25379423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
    Mangialasche F; Westman E; Kivipelto M; Muehlboeck JS; Cecchetti R; Baglioni M; Tarducci R; Gobbi G; Floridi P; Soininen H; Kłoszewska I; Tsolaki M; Vellas B; Spenger C; Lovestone S; Wahlund LO; Simmons A; Mecocci P;
    J Intern Med; 2013 Jun; 273(6):602-21. PubMed ID: 23343471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.
    Westman E; Simmons A; Zhang Y; Muehlboeck JS; Tunnard C; Liu Y; Collins L; Evans A; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Spenger C; Wahlund LO;
    Neuroimage; 2011 Jan; 54(2):1178-87. PubMed ID: 20800095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Misra C; Fan Y; Davatzikos C
    Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.
    Westman E; Aguilar C; Muehlboeck JS; Simmons A
    Brain Topogr; 2013 Jan; 26(1):9-23. PubMed ID: 22890700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
    Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects.
    Falahati F; Ferreira D; Soininen H; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Lovestone S; Eriksdotter M; Wahlund LO; Simmons A; Westman E;
    Brain Topogr; 2016 Mar; 29(2):296-307. PubMed ID: 26440606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment.
    Aguilar C; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kloszewska I; Soininen H; Lovestone S; Spenger C; Simmons A; Wahlund LO
    Psychiatry Res; 2013 May; 212(2):89-98. PubMed ID: 23541334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.
    Simmons A; Westman E; Muehlboeck S; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Wahlund LO; Soininen H; Lovestone S; Evans A; Spenger C
    Int J Geriatr Psychiatry; 2011 Jan; 26(1):75-82. PubMed ID: 21157852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts.
    Khan W; Westman E; Jones N; Wahlund LO; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Muehlboeck JS; Simmons A;
    Brain Topogr; 2015 Sep; 28(5):746-759. PubMed ID: 25370484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
    Moradi E; Pepe A; Gaser C; Huttunen H; Tohka J;
    Neuroimage; 2015 Jan; 104():398-412. PubMed ID: 25312773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally linear embedding (LLE) for MRI based Alzheimer's disease classification.
    Liu X; Tosun D; Weiner MW; Schuff N;
    Neuroimage; 2013 Dec; 83():148-57. PubMed ID: 23792982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
    Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
    J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI measures of Alzheimer's disease and the AddNeuroMed study.
    Simmons A; Westman E; Muehlboeck S; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Wahlund LO; Soininen H; Lovestone S; Evans A; Spenger C;
    Ann N Y Acad Sci; 2009 Oct; 1180():47-55. PubMed ID: 19906260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment.
    Spulber G; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Wahlund LO; Westman E;
    J Intern Med; 2013 Apr; 273(4):396-409. PubMed ID: 23278858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
    Teipel SJ; Born C; Ewers M; Bokde AL; Reiser MF; Möller HJ; Hampel H
    Neuroimage; 2007 Oct; 38(1):13-24. PubMed ID: 17827035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.